2 active trials 2 recruiting 1 disease areas 1 changes in 30 days
| Phase 2 | 2 |
| NCT ID | Title | Condition | Status | Updated |
|---|---|---|---|---|
| Phase 2 | ||||
| NCT06747858 | Safety, Tolerability and Efficacy Study of ARCT-032 in People With Cystic Fibrosis | Cystic Fibrosis | Recruiting | 2026-05-08 |
| NCT06488313 | A Study to Evaluate the Pharmacodynamics and Safety of ARCT-810 in Participants With OTCD | OTC Deficiency | Recruiting | 2025-03-17 |
Cystic Fibrosis (1)